Noradrenaline reuptake inhibitors (NRIs) for attention deficit hyperactivity disorder (ADHD) in adults.
- DOI
- 10.1177/09246479261461033
- Published
- 2026 Sep 17
- Container
- The International journal of risk & safety in medicine
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1177/09246479261461033,
title = {Noradrenaline reuptake inhibitors (NRIs) for attention deficit hyperactivity disorder (ADHD) in adults.},
author = {Nurkhametova D and Yudina EV and Wei Y and Abakumova T and Ziganshina LE},
year = {2026},
journal = {The International journal of risk \& safety in medicine},
doi = {10.1177/09246479261461033},
url = {https://doi.org/10.1177/09246479261461033}
}RIS
TY - JOUR TI - Noradrenaline reuptake inhibitors (NRIs) for attention deficit hyperactivity disorder (ADHD) in adults. AU - Nurkhametova D AU - Yudina EV AU - Wei Y AU - Abakumova T AU - Ziganshina LE PY - 2026 JO - The International journal of risk & safety in medicine DO - 10.1177/09246479261461033 UR - https://doi.org/10.1177/09246479261461033 ER -
APA
D, N., EV, Y., Y, W., T, A., & LE, Z. (2026). Noradrenaline reuptake inhibitors (NRIs) for attention deficit hyperactivity disorder (ADHD) in adults.. The International journal of risk & safety in medicine. https://doi.org/10.1177/09246479261461033
Source records
- pubmed · retrieved 2026-09-26T15:16:55.773Z